Intrauterine Contraceptive Marketis segmented by Device (Hormonal Intrauterine, Copper Intrauterine), End User (Hospitals, Gynecology Clinics, Community Health Care Centers), and Region (North America, Europe, Asia-Pacific, and the Rest of the World).
Intrauterine Contraceptive Market is segmented by Device (Hormonal Intrauterine, Copper Intrauterine), End User (Hospitals, Gynecology Clinics, Community Health Care Centers), and Region ...
The Intrauterine Contraceptive Marketis expected to witness an impressive growth of 10.2% CAGR in the coming years.
An intrauterine device (IUD) is a small contraceptive device, usually 'T'-shaped, consisting of either copper or levonorgestrel, which is inserted into the uterus. It is one form of long-acting reversible contraception, which is the most effective type of reversible birth control.
The key factors include technological innovations resulting ineffective contraception and fewer side effects, the rising rate of unintended pregnancies, and supportive government initiatives & private firms for the prevention of unwanted abortions and pregnancies, which boosts the market growth. Also, the market is largely driven by the growing rate of unintended pregnancies and unwanted abortions. Moreover, the long-term efficacy and rising acceptance are likely to augment the growth of the intrauterine contraceptive devices market.
The COVID-19 outbreak negatively affected the growth of the Intrauterine Contraceptive market. During the pandemic with rising cases of COVID-19 across the globe, the health care emphasis has shifted to focus on the apportionment of resources, emergent medical care, prevention of viral spread, and the development of novel treatments and vaccines. Moreover, the unfortunate by-product of this shift is the de-prioritization of other essential health care services such as access to contraception, thus affecting the industry's growth.
The market has been classified into hormonal intrauterine and copper intrauterine. The copper intrauterine segment accounted for a substantial market share in 2020. Copper IUDs have been in the market for a very long time, since 1988, earlier than the hormonal IUDs. One of the benefits of using copper IUDs is that they can be used as emergency contraceptives. Also, they can be used within five days of unprotected intercourse to avoid pregnancy.
Regional Analysis
The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the large presence of advanced healthcare infrastructure, rise in demand for intrauterine contraceptives, as well as presence of major market participants. IUDs are one of the most effective forms of reversible contraception, and the interest in this method is rising among women and healthcare providers in the region. The US has shown the greatest demand in the use of both hormone-free copper, as well as hormone-based IUDs, which further proliferates regional growth.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What deliverables will you get in this report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
In-depth analysis of the Intrauterine Contraceptive Market
How lucrative is the future?
Market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional and country level historical data and forecasts
Which are the most attractive market segments?
Market segment analysis and forecast
Which are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirement?
10% free customization
Target Audience
Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-
Distributors
Suppliers
Manufacturers
Logistics organizations
Government bodies
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.
Customization Options
Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to three players)
SWOT analysis of key players (up to three players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
An intrauterine device (IUD) is a small contraceptive device, usually 'T'-shaped, consisting of either copper or levonorgestrel, which is inserted into the uterus. It is one form of long-acting reversible contraception, which is the most effective type of reversible birth control.
The technological innovations resulting ineffective contraception and fewer side effects, the rising rate of unintended pregnancies are the factors driving the growth of intrauterine contraceptive market.
Abbvie Inc (Allergan Plc) (US), Bayer AG (Germany), CooperSurgical Inc. (US), DKT Internation-al (US), EUROGINE, S.L (Luxembourg), Mona Lisa NV (Belgium), Pregna International Limited (India), Prosan International BV (Netherlands), SMB Corporation of India (India), and Melbea AG (US) are among the key players in the intrauterine contraceptive market.
